150
A. Graziani et al. / Carbohydrate Research 339 (2004) 147–151
0.43 mmol) in dry MeCN (1.5 mL) was added and the
mixture was stirred at room temperature for 2 h under
N2. Monitoringof the reaction by TLC showed the
formation of intermediate phosphite triesters (2.5:7.5,
n-hexane–diethyl ether). The reaction mixture contain-
ingphosphite triesters was cooled to 0 ꢁC and a soln of
t-BuOOH (35 lL of an 80% soln in di-tert-butyl per-
oxide) in CH2Cl2 (1.5 mL) was gradually added
(ꢀ20 min). The reaction mixture was warmed to room
temperature and stirred for 12 h. The solvent was
1H, 3J5;6 2.5 Hz, H-5), 4.26 (dd, 1H, 3J7b;6 7.6 Hz, H-7b),
3.16 (q, 6H, NCH2), 2.15, 2.11, 2.09, 2.04, 1.99 (5s, 15H,
5Ac), 1.24 (t, 9H, CH3, Et3N).
1.4. Guanosine 50-(
diphosphate (triethylammonium salt) (6)
D
-glycero-a- -manno-heptopyranosyl)
D
Pentaacetyl heptosyl phosphate 3 (20 mg, 0.0334 mmol)
was made anhyd by repeated dissolution in dry pyridine
and evaporation (4 · 10 mL). After each evaporation
step, dry N2 was flushed into the rotary evaporator.
Guanosine-50-monophosphate morpholidate (40-mor-
pholine-N,N0-dicyclohexylcarboxamidinium salt) (36 mg,
0.0496 mmol) was dissolved in dry pyridine and evapo-
rated to dryness and the process was repeated three
times with exclusion of moisture under N2. Both com-
ponents were finally dissolved in pyridine and combined
in a one-neck round-bottom flask under N2-atmosphere.
The reaction mixture was repeatedly evaporated from
pyridine (3 · 10 mL) and flushed with dry N2. A final
amount of pyridine (10 mL) was added to give a clear
solution. About 70% of pyridine was removed by con-
centration and the reaction vessel was sealed under N2.
The solution was vigorously stirred and the progress of
the reaction was monitored by TLC-analysis (35:20:2:2,
CHCl3–MeOH–25% aq NH4OH–H2O). The reaction
was kept for 3 days and progress was monitored by the
appearance of a major UV-positive spot of GDP-Hep.
The reaction was stopped by evaporation of pyridine.
The diphosphate 5 was isolated usinganion-exchange
chromatography. The crude reaction products were
dissolved in 10 mL water and the soln was allowed to
slowly adsorb on a resin bed of anion-exchange column
(BioRad, 5 mL cartridge, HCOÀ2 -form) connected to an
FPLC-system. The column was operated at 0.7 mL/min,
fractions (1 mL) were collected. The column was washed
first with water and was then developed with a linear
gradient of TEAB buffer. The eluate was monitored at
280 nm, 5 was eluted at a concentration of ꢀ0.15 M
TEAB. The fractions containingGDP-Hep were pooled,
concentrated to 10 mL vol, the soln was cooled to 0 ꢁC,
and the pH was adjusted to 4.5 with Dowex 50 (Hþ)
resin. The resin was removed by filtration, the total
eluate was made neutral by addition of Et3N, concen-
trated to 5 mL vol at 25 ꢁC and lyophilized to give
evaporated usinga stream of N . The residue was re-
2
dissolved in diethyl ether and washed sequentially with
saturated aq NaHCO3–water and brine. The organic
phase was dried (Na2SO4) and concentrated. The a- and
b-phosphates were separated by chromatography on
silica gel (1:9, n-hexane–diethyl ether) to give 2 (62 mg,
65%) as a syrup. Rf 0.40; analytical data were similar to
the previously described compound.11 1H NMR
3
(CDCl3): d 7.37–7.33 (m, 10H, 2Ph), 5.57 (dd, 1H, J1;2
1.7, 3J1;P 6.5 Hz, H-1), 5.30 (t, 1H, 3J4;3 ¼ 3J4;5 9.8 Hz, H-
4), 5.28 (d, 1H, 3J3;2 3.3 Hz, H-3), 5.21–5.14 (m, 2H, H-2,
3
H-6), 5.09 (d, 2H, JH;P 8.5 Hz, CH2Ph), 5.08 (d, 2H,
3
2
3JH;P 8.5 Hz, CH2Ph), 4.33 (dd, 1H, J7a;6 4.0, J7a;7b
3
12.0 Hz, H-7a), 4.19 (dd, 1H, J7b;6 7.7 Hz, H-7b), 4.15
(m, 1H, H-5), 2.13, 2.09, 2.03, 1.99 and 1.93 (5s, 15H,
5Ac).
Further elution gave 4 (4.8 mg, 5%) as a syrup. Rf
0.24; 1H NMR (CDCl3): d 7.37–7.29 (m, 10H, 2Ph), 5.47
3
3
3
(dd, 1H, J1;2 1.5, J1;P 7.8 Hz, H-1), 5.42 (dd, 1H, J2;1
1.5, 3J2;3 3.3 Hz, H-2), 5.26 (t, 1H, 3J4;3 ¼ 3J4;5 9.3 Hz, H-
4), 5.25 (m, 1H, H-6), 5.10 (d, 2H, 3JH;P 8.0 Hz, CH2Ph),
5.05 (d, 2H, 3JH;P 8.0 Hz, CH2Ph), 5.04 (dd, 1H, 3J3;4 9.3,
3J3;2 3.3 Hz, H-3), 4.41 (dd, 1H, 3J7a;6 3.6, 2J7a;7b 12.0 Hz,
3
H-7a), 4.25 (dd, 1H, J7b;6 7.0 Hz, H-7b), 4.15 (dd, 1H,
3J5;6 3.7 Hz, H-5), 2.13, 2.10, 2.04, 2.01 and 1.99 (5s,
15H, 5Ac).
1.3. 2,3,4,6,7-Penta-O-acetyl-
heptopyranosyl phosphate (triethylammonium salt) (3)
D
-glycero-a- -manno-
D
A soln of 2 (23 mg, 0.034 mmol) in dry MeOH
(7 mL) was hydrogenated in the presence of 10% Pd/C
(7 mg) for 10 h at atmospheric pressure. After comple-
tion of the reaction, the catalyst was removed by filtra-
tion through a pad of Celite and washed with MeOH.
The combined filtrates were neutralized by addition of
Et3N (0.1 mL) and concentrated. The residue was lyo-
philized from water to give the triethylammonium salt of
3 (20 mg, 98%) as a white fluffy solid which was used in
the next step without further purification. Rf 0.34
guanosine 50-(2,3,4,6,7-penta-O-acetyl-
D
-glycero-a-D-
manno-heptopyranosyl) diphosphate (triethylammo-
nium salt) (5) as a solid. Yield: 20.7 mg(65%); Rf 0.37
(35:20:2:2, CHCl3–MeOH–25% aq NH4OH–water); 31P
2
1
NMR: d )11.0 (d, JP;P 19 Hz; PRib), )14.2 (d, PHep); H
NMR (D2O): d 8.11 (br s, 1H, H-8Gua), 5.91 (d, 1H, 3J1;2
1
(35:20:2:2, CHCl3–MeOH–25% aq NH4OH–water); H
NMR (D2O): d 5.42 (dd, 1H, 3J1;P 7.5, 3J1;2 2.0 Hz, H-1),
5.38 (dd, 1H, 3J2;3 2.9, 3J3;4 9.8 Hz, H-3), 5.30 (t, 1H, 3J4;5
9.8 Hz, H-4), 5.26 (br s, 1H, H-2), 5.25 (ddd, 1H, H-6),
5.8 Hz, H-1Rib), 5.58 (dd, 1H, J1;2 1.8, J1;P 7.5 Hz, H-
Hep), 5.36 (m, 1H, H-2Hep), 5.35–5.28 (m, 2H, H-3Hep
H-4Hep), 5.22 (m, 1H, H-6Hep), ꢀ4.73 (H-2Rib, under-
neath the water signal), 4.49 (dd, 1H, J3;4 5.1, J3;2
3
3
1
,
3
2
3
3
4.43 (dd, 1H, J7a;6 3.4, J7a;7b 12.0 Hz, H-7a), 4.40 (dd,